Press Releases

Apr 13, 2004 Hemispherx Biopharma to Present First Phase 3 Data on Ampligen in Chronic Fatigue Syndrome at the 17th International Conference on Antiviral Research

Mar 18, 2004 Hemispherx Biopharma Completes Acquisition for Worldwide Rights to Alferon N

Mar 15, 2004 HEMISPHERX BIOPHARMA REPORTS 2003 YEAR-END RESULTS

Mar 02, 2004 HEMISPHERX BIOPHARMA ANNOUNCES FDA AUTHORIZATION FOR A CLINICAL STUDY WITH NEW BIOLOGICAL ALFERON LDO FOR HIV

Feb 25, 2004 HEMISPHERX BIOPHARMA TO PRESENT AT WALL STREET ANALYST FORUM ON MARCH 1st

Feb 18, 2004 HEMISPHERX BIOPHARMA SIGNS OPTION AGREEMENT FOR AMPLIGEN WITH FUJISAWA PHARMACEUTICAL COMPANY

Jan 30, 2004 HEMISPHERX BIOPHARMA FINISHES PHASE 3 CFS CLINICAL TRIAL

Jan 26, 2004 HEMISPHERX BIOPHARMA REPORTS PUBLICATION SUGGESTING EFFICACY OF AMPLIGEN IN TREATING MYOCARDITIS VIRUS

Jan 20, 2004 HEMISPHERX BIOPHARMA ANNOUNCES JOINT WEST NILE VIRUS CLINICAL PROGRAM WITH NEW YORK HOSPITAL

Jan 13, 2004 Hemispherx Biopharma Announces Joint SARS Clinical Program with Vanderbilt University

64 65 66 67 68 69 70 71 72 73 74

<< < > >>